News & Events Press Releases Read More Yale’s Adam Mecca, MD, PhD Discusses ALX-001 with NeurologyLive November 14, 2023 Read More Allyx sets Phase II plans for AD in motion after Phase Ia October 31, 2023 Read More NIA Small Business Showcase: Allyx Therapeutics, Inc. June 15, 2022 Read More Bristol Myers drug candidate repairs neuronal damage in Alzheimer’s mouse models Read More Allyx, BMS and Yale Announce License Agreement January 13, 2021 Read More Drug Restores Cells and Memories in Alzheimer’s Mouse Models July 5, 2017 Read More Yale Discovery Could Lead to Alzheimer’s Drug, Restored Memory September 3, 2013 Upcoming Presentations Check back soon for upcoming presentations…
